[On-Demand Streaming Available] 10/6 (Wed) International Webinar 'Simplifying the mRNA Process_Part 2: Why Multi-Column Chromatography is Superior to Batch_Throughput Analysis'

Sartorius Stedim Japan K.K.

Participation in this webinar has ended. Those who wish to view it on demand can register for details and access it after registration. The mRNA vaccine plays a crucial role in combating SARS-CoV-2, and the necessity to produce mRNA has never been greater due to the ongoing development of treatments for various indications. In Part 2, the product manager and product specialist of the BioSMB system will explain how multi-column chromatography is superior to batch chromatography and how it can increase throughput by up to six times. They will also introduce traditional batch processes and demonstrate how BioSMB can be easily integrated into existing processes without compromising purification performance, throughput, or quality. [Topics] ▪ How batch chromatography limits throughput and increases resin costs ▪ How to improve throughput with less resin using BioSMB's multi-column cycling ▪ An analysis of how increased throughput reduces time to scale-up and the facility footprint.

Date and time Wednesday, Oct 06, 2021
11:00 PM ～
Capital
Entry fee Free

Related product information

BioSMB Process 80 | 350 System
Single-use continuous production chromatography system, bioreactor process for perfusion and batch processes.

The BioSMB process system uses the principles of multi-column chromatography to enable manufacturers to efficiently utilize resins at clinical and commercial scales, significantly reducing resin costs. The BioSMB platform is the first market solution that allows for scale-up from process development to commercial production with single-use capabilities. These systems facilitate the direct replacement of a single chromatography unit operation within batch processes, providing an optimal entry point for process intensification downstream.
BioSMB PD System
Continuous production single-use multi-column chromatography

The BioSMB platform is a fully scalable continuous production multi-column chromatography solution that enables process development (PD) in the lab to GMP manufacturing through disposable flow paths. It is specially designed to convert continuous production chromatography without changing chromatography resins, buffer systems, or product quality testing from existing batch processes. The BioSMB technology provides process consistency across all scales, including development, clinical, and full production, and allows for flexible use in a variety of product facilities.

Related catalog

BioSMB Process 80 System | BioSMB Process 350 System

PRODUCT

Contact this catalog

BioSMB PD System

PRODUCT

Contact this catalog

Return to news list